Lichen Striatus Pathology: Key Insights For Accurate Diagnosis

Lichen striatus is a benign, self-limited inflammatory dermatosis characterised by a linear arrangement of papules following the lines of Blaschko, primarily affecting children. This condition arises from T-cell mediated immune responses targeting epidermal keratinocytes, leading to distinctive histopathological changes observable under microscopy.

Introduction

Lichen striatus, also known as Blaschko linear acquired inflammatory skin eruption, manifests as pink or skin-coloured papules coalescing into linear bands. It is uncommon, with an estimated incidence of 1 in 100,000 children annually, though exact figures vary due to underreporting of mild cases. The pathology involves clonal keratinocyte abnormalities distributed along embryonic migration pathways, triggered by genetic mosaicism or environmental factors. Histologically, it shows interface dermatitis with lichenoid infiltration, distinguishing it from other linear dermatoses.

The condition’s self-limiting nature typically sees resolution within 3-12 months without scarring, though post-inflammatory pigmentary changes may persist. Understanding its pathology is crucial for accurate diagnosis, as clinical features alone can mimic infections or other eruptions.

Demographics

Lichen striatus predominantly affects children under 15 years, with peak onset between 1-5 years. Approximately 80-90% of cases occur in this age group, with females slightly more affected (ratio 1.5:1). It is rare in adults and neonates. No strong racial predilection exists, though hypopigmented variants are noted in darker skin types. Familial cases are exceptional, suggesting sporadic somatic mutations rather than inherited traits.

• Age distribution: 94% under 15 years; median age 3 years.
• Gender: Slight female predominance.
• Risk factors: Atopy (20-30% association), recent viral infections, vaccinations, or trauma.

Clinical Features

The eruption begins abruptly with small (1-3 mm), flat-topped papules that are pink, red, flesh-coloured, or hypopigmented, especially in darker skin. Over 1-2 weeks, these coalesce into dull red, slightly scaly linear bands (2 mm-2 cm wide), following Blaschko’s lines—patterns of embryonic ectodermal cell migration invisible on normal skin. Lesions are typically unilateral and solitary, affecting extremities (70%), but can involve trunk, neck, or face.

Symptoms are minimal; mild pruritus occurs in 20-50% of cases. Nail involvement (5-10%) presents as ridging, thickening, splitting, or onycholysis, occasionally without skin lesions. In dark-skinned individuals, initial hypopigmentation predominates, resolving to post-inflammatory hyperpigmentation.

Blaschko’s lines on limbs run longitudinally, curve into S-shapes on the abdomen, and form V-shapes on the back, explaining the morphology.

Pathogenesis

The exact aetiology remains elusive, but lichen striatus is considered a T-cell mediated reaction to mosaic keratinocyte clones arising from somatic mutations during embryogenesis. These clones express neoantigens, provoking CD8+ T-lymphocyte infiltration along Blaschko’s lines. Atopy predisposes via impaired skin barrier function, and triggers include viruses (e.g., adenovirus, EBV), vaccinations, or trauma, activating inflammatory cascades.

Genetic studies reveal loss-of-heterozygosity in affected skin, supporting mosaicism. Cytokine profiles show elevated IL-2 and IFN-γ, consistent with type 1 immune responses. Unlike genetic mosaic disorders (e.g., incontinentia pigmenti), lichen striatus is acquired postnatally.

Histopathology

Skin biopsy reveals a lichenoid interface dermatitis: dense band-like lymphocytic infiltrate at the dermo-epidermal junction, obscuring the basal layer. Parakeratosis, hyperkeratosis, and spongiosis are mild. Vacuolar degeneration of basal keratinocytes, Civatte bodies (dyskeratotic cells), and exocytosis of lymphocytes into the epidermis are hallmarks. Melanophages in the dermis account for post-inflammatory pigmentation.

• Key features: Lichenoid infiltrate (perivascular and interface), basal vacuolization, scattered dyskeratosis.
• Absent: Granular cell layer changes (vs. lichen planus), viral inclusions.
• Nail biopsy (rare): Similar interface changes in matrix epithelium.

Immunohistochemistry shows CD8+ T-cells predominant, with CD4+ helpers; rare eosinophils differentiate from eczematous conditions. Electron microscopy (historical) demonstrates tonofilament clumping in keratinocytes.

Diagnosis

Diagnosis is primarily clinical, based on linear papules along Blaschko’s lines in a child. Dermoscopy reveals structureless pink bands with white scales. Biopsy confirms in atypical cases. Wood’s lamp may highlight hypopigmentation.

Differential Diagnosis

Rule out contact dermatitis or infections via history and swabs.

Treatment

Asymptomatic cases require reassurance; spontaneous resolution occurs in 6-12 months (range 1 month-3 years). Post-inflammatory hypopigmentation/hyperpigmentation fades over months, affecting 50%.

• First-line: Emollients for dryness.
• Pruritus: Low-mid potency topical corticosteroids (e.g., hydrocortisone 1% twice daily, 2-4 weeks).
• Resistant: Topical calcineurin inhibitors (tacrolimus 0.03%, pimecrolimus 1%).
• Nails: High-potency steroids under occlusion.
• Other: Topical retinoids + steroids, photodynamic therapy (rare).

Avoid systemic steroids unless extensive. Monitor for recurrence (rare, <5%).

Complications and Prognosis

Complications are minimal: transient pigmentary changes (most common), nail dystrophy (reversible), rare koebnerization. Prognosis is excellent; no scarring or long-term sequelae. Recurrence is uncommon but reported post-trauma.

Frequently Asked Questions (FAQs)

Q: Is lichen striatus contagious?

A: No, it is a non-infectious inflammatory condition, not spread by contact.

Q: How long does lichen striatus last?

A: Typically 3-12 months, averaging 9 months; full resolution without marks in most cases.

Q: Can adults get lichen striatus?

A: Rare, but possible; termed ‘adult Blaschkitis’ if flexural.

Q: Does lichen striatus scar?

A: No permanent scarring; temporary pigment changes may occur.

Q: Is biopsy always needed?

A: No, clinical diagnosis suffices; biopsy for atypical presentations.

Q: Can lichen striatus follow vaccination?

A: Yes, temporal association reported with viral vaccines, including COVID-19.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

medha deb

 

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb